Coalition to Advance Maternal Therapeutics

SMFM jointly launched the Coalition to Advance Maternal Therapeutics (CAMT) with the American Academy of Pediatrics, the American Congress of Obstetricians and Gynecologists, and the March of Dimes. CAMT's guiding principles support advocacy efforts to better understand the safety and efficacy of prescription drugs, therapeutics, and vaccines used during pregnancy and breastfeeding.

Other members of CAMT include:

• American College of Nurse-Midwives 
  
• Association of Maternal & Child Health Programs 
  
• Association of Women’s Health, Obstetric, and Neonatal Nurses
  
• National Association of Nurse Practitioners in Women’s Health 
  
• Society for Women’s Health Research
  

SUCCESS! - Included within the 21st Century Cures Act (P.L. 114-255) is a provision which establishes an federal task force to identify and address gaps in knowledge and research regarding safe and effective therapies for pregnant and lactating women. Within two years, the task force will develop a report to Congress with specific recommendations for addressing the issues identified. SMFM will monitor the Task Force and provide updates as it begins its work. 

June 20, 2017: SMFM and members of the Steering Committee of the Coalition to Advance Maternal Therapeutics wrote to Secretary Price to ask that he move quickly and approve a slate of members for the Task Force on Research Specific to Pregnant Women and Lactating Women.

January 4, 2017: SMFM urges the Secretary of Health and Human Services to begin implementation of the Task Force on Research Specific to Pregnant Women and Lactating Women as soon as possible, and to include a MFM on the Task Force.